510(k) Report

510(k) · Cleared

Cleared

Xenform Soft Tissue Repair Matrix

K051190510(k) SpecialCleared Jun 10, 200531-day reviewClass II21 CFR 878.3300

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Tei Biosciences, Inc. · PAJ Mesh, Surgical, Non-Synthetic, Urogynecologic, For Apical Vaginal And Uterine Prolapse, Transabdominally Placed

Cleared on Jun 10, 2005 as substantially equivalent to K020455 (Tei Biosciences, Inc., 2002) after a 31-day review. Its family tree reaches back 4 generations to 1992. 1 later device descends from it.

Decided
Jun 10, 2005
Review
31 days
Class
Class II
Product code
PAJ
Recalls
None
Predicates
1

Its longest line of descent runs back 4 generations to K921895 (1992). 8 ancestors in all, the oldest K830889 (1983). 1 later device descends from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2000: 1 other ancestor1997: 1 other ancestor1983: 1 other ancestor1992: 1 other ancestor2006: 1 descendant clearedK921895 · Tissue Patch, Tissue Graft · Bio-Vascular, Inc. · 1992K961810 · Supple Peri-Guard Pericardium · Bio-Vascular, Inc. · 1996K980431 · Surgisis · Cook Biotech, Inc. · 1998K020455 · Tissuemend Soft Tissue Repair Matrix · Tei Biosciences, Inc. · 200219801990200020102020
Other ancestors, by generationDescendants, by generation 2 generations back: 1 other ancestor3 generations back: 2 other ancestors4 generations back: 1 other ancestor 1 generation forward: 1 descendant K020455 · Tissuemend Soft Tissue Repair Matrix · Tei Biosciences, Inc. · 2002K980431 · Surgisis · Cook Biotech, Inc. · 1998K961810 · Supple Peri-Guard Pericardium · Bio-Vascular, Inc. · 1996K921895 · Tissue Patch, Tissue Graft · Bio-Vascular, Inc. · 19920
  1. Root · 4 generations backK921895 Tissue Patch, Tissue GraftBio-Vascular, Inc. · 1992
  2. 3 generations backK961810 Supple Peri-Guard PericardiumBio-Vascular, Inc. · 1996
  3. 2 generations backK980431 SurgisisCook Biotech, Inc. · 1998
  4. 1 generation backK020455 Tissuemend Soft Tissue Repair MatrixTei Biosciences, Inc. · 2002
  5. This deviceK051190 Xenform Soft Tissue Repair MatrixTei Biosciences, Inc. · 2005
  6. Descendant · cites it directly · 0 of its ownK060984 Xenform Soft Tissue Repair MatrixTei Biosciences, Inc. · 2006

Most influential descendants

Showing 1 of 1 · See all
  • K060984Xenform Soft Tissue Repair MatrixTei Biosciences, Inc. · 2006 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K921895Tissue Patch, Tissue GraftBio-Vascular, Inc.1992—
−3K961810Supple Peri-Guard PericardiumBio-Vascular, Inc.1996—
−2K980431SurgisisCook Biotech, Inc.1998—
−1K020455Tissuemend Soft Tissue Repair MatrixTei Biosciences, Inc.2002—
0 (this device)K051190Xenform Soft Tissue Repair MatrixTei Biosciences, Inc.2005—
+1K060984Xenform Soft Tissue Repair MatrixTei Biosciences, Inc.2006—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198310
199210
199710
200010

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200610
FIG. 1 — Lineage of K051190, 1992–2006Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in PAJ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K020455Tissuemend Soft Tissue Repair Matrix
Summary page 2
…ivalence is Being Claimed Xenform is substantially equivalent in function and intended use to: Predicate Devices Manufacturer 510(k) Number . TissueMend TEI Biosciences K020455 Summary of Technological Characteristics and Biocompatibility Xenform Soft Tissue Repair Matrix is substantially equivalent to o…
Tei Biosciences, Inc.2002—

Also cleared against K020455: 4 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K060984Xenform Soft Tissue Repair MatrixTei Biosciences, Inc.20060

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 13 years and passes through 3 companies; a new generation was cleared every 3.6 years on median.
  • None of the 8 ancestors has a recall.
  • Of its descendants, K060984 (Tei Biosciences, Inc., 2006) has gone furthest, with 0 descendants of its own.
  • 4 other devices also cite its predicate K020455.

How does its category compare?

All PAJ devices

PAJ Mesh, Surgical, Non-Synthetic, Urogynecologic, For Apical Vaginal And Uterine Prolapse, Transabdominally Placed: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · PAJ

FDA has decided no PAJ device since 2007.

Median 510(k) review, days · PAJ

Too few PAJ 510(k)s in any year since 2007 to give a median.

Recalls per year · PAJ

No recall names PAJ since 2007.

Adverse event reports per year · PAJ

2in 2019

2013: 612014: 662015: 2862016: 2672017: 962018: 92019: 2
2007high 286 (2015) · low 0 (2007)2025

MAUDE reports naming product code PAJ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—061
20140—066
20150—0286
20160—0267
20170—096
20180—09
20190—02
20200—00
20210—00
20220—00
20230—00
20240—00
20250—00
20260—0—

What is it indicated for?

Xenform Soft Tissue Repair Matrix is intended for use as a soft tissue patch to reinforce soft tissue where weakness exists and for the surgical repair of damaged or ruptured soft tissue membranes. It is specifically indicated for the repair of colon, rectal, urethral, and vaginal prolapse; reconstruction of the pelvic floor; and procedures such as sacrocolposuspension and urethral sling.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K051190: Xenform Soft Tissue Repair Matrix.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K051190

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026